International
The Morning Science

What science found today

‹
 

Topic

daraxonrasib

3 stories about daraxonrasib that passed the news check, newest first.

  1. Research ·

    'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

    The first-in-class RAS inhibitor daraxonrasib (Rasonque), combined with chemotherapy, showed promise as a first-line treatment for metastatic pancreatic adenocarcinoma (PDAC).

    MedPageToday.com - medical news for physicians

  2. Research ·

    Erasca data add to pressure facing Revolution’s breakthrough cancer drug

    Erasca reported data on its KRAS-targeted drug in pancreatic cancer, adding pressure on Revolution Medicines' drug Rasonque, according to BioPharma Dive.

    BioPharma Dive - Latest News · 2 sources

  3. Research ·

    expert reaction to abstract about Daraxonrasib plus GnP for metastatic pancreatic adenocarcinoma

    An abstract presented at EORTC-NCI-AACR 2026 reports on daraxonrasib plus GnP for metastatic pancreatic adenocarcinoma.

    Science Media Centre